Marshall Wace’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$622K Sell
73,292
-346,282
-83% -$2.3M ﹤0.01% 2421
2026
Q1
$2.29M Buy
419,574
+357,650
+578% +$2.01M ﹤0.01% 1710
2025
Q4
$433K Sell
61,924
-27,613
-31% -$216K ﹤0.01% 2300
2025
Q3
$692K Buy
+89,537
New +$699K ﹤0.01% 2106
2025
Q2
Sell
-84,995
Closed -$677K 3166
2025
Q1
$677K Buy
+84,995
New +$860K ﹤0.01% 1943
2024
Q4
Sell
-394,133
Closed -$3.62M 3000
2024
Q3
$3.62M Buy
+394,133
New +$3.26M ﹤0.01% 1122
2023
Q4
Sell
-36,819
Closed -$684K 2605
2023
Q3
$684K Buy
+36,819
New +$859K ﹤0.01% 1617
2023
Q1
Sell
-14,434
Closed -$341K 3095
2022
Q4
$341K Buy
+14,434
New +$389K ﹤0.01% 2518
2022
Q3
Sell
-74,509
Closed -$2.47M 3782
2022
Q2
$2.47M Sell
74,509
-1,477,611
-95% -$62.8M 0.01% 1842
2022
Q1
$112M Buy
1,552,120
+1,114,090
+254% +$80.3M 0.21% 96
2021
Q4
$40.2M Buy
438,030
+180,654
+70% +$21.6M 0.07% 265
2021
Q3
$32.6M Buy
257,376
+26,308
+11% +$3.83M 0.14% 146
2021
Q2
$38.4M Sell
231,068
-17,394
-7% -$2.82M 0.17% 115
2021
Q1
$45.2M Buy
248,462
+218,733
+736% +$50.7M 0.21% 96
2020
Q4
$5.94M Buy
+29,729
New +$6.04M 0.03% 508

Other funds holding TDOC

Marshall Wace's TDOC Position: Q2 2026 in Review

Marshall Wace reduced its Teladoc Health (TDOC) stake by 83% in Q2 2026, selling an estimated $2.3M and leaving 73,292 shares worth $622K. The position accounts for ﹤0.01% of the portfolio, ranked #2421.

Marshall Wace first reported a position in TDOC in Q4 2020 and has held it in 15 quarters since. The position peaked at $112M in Q1 2022. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Marshall Wace held 73,292 shares of Teladoc Health worth $622K as of Q2 2026.
  • Marshall Wace sold 346,282 Teladoc Health shares in Q2 2026, an estimated $2.3M.
  • Teladoc Health made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2421 holding.
  • Marshall Wace first reported a position in Teladoc Health in Q4 2020 and has held it in 15 quarters since.
  • Marshall Wace's Teladoc Health position peaked at $112M in Q1 2022.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.